Levi & Korsinsky, LLP Investigates Possible Breach of Fiduciary Duty by the Board of BioForm Medical, Inc. – BFRM

Levi & Korsinsky is investigating the Board of Directors of BioForm Medical, Inc. (“BioForm” or the “Company”) (NasdaqGM: BFRM) for possible breaches of fiduciary duty.

New York, NY, January 05, 2010 — Levi & Korsinsky is investigating the Board of Directors of BioForm Medical, Inc. (“BioForm” or the “Company”) (NasdaqGM: BFRM) for possible breaches of fiduciary duty and other violations of state law in connection with their attempt to sell the Company to Merz Pharma Group (“Merz Pharma”). Under the terms of the deal, BioForm shareholders will receive $5.45 in cash for each share of BioForm they own for a total transaction value of approximately $253 million.

The investigation concerns whether the BioForm Board of Directors breached their fiduciary duties to BioForm stockholders by failing to adequately shop the Company before entering into this transaction and whether Merz Pharma is underpaying for BioForm shares, thus unlawfully harming BioForm stockholders.

If you own common stock in BioForm and wish to obtain additional information, please contact us at the number listed below or visit http://www.zlk.com/bfrm1.html.

Levi & Korsinsky has expertise in prosecuting investor securities litigation and extensive experience in actions involving financial fraud and represents investors throughout the nation, concentrating its practice in securities and shareholder litigation.

CONTACT: Levi & Korsinsky, LLP, Joseph Levi, Esq. Eduard Korsinsky, Esq. 30 Broad Street – 15th Floor, New York, NY 10004 Tel: (212) 363-7500, Fax: (212) 363-7171, www.zlk.com
Press Release Distribution By PressReleasePoint

Press Contact:
Joseph Levi
Levi & Korsinsky, LLP
30 Broad Street, 15th Floor
New York, NY 10004
212-363-7500
info@zlk.com

http://www.zlk.com